Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

10 people dead in Bondi shotin...

00:05:30

10 people dead in Bondi shoting, including one shooter

The Anton Savage Show

00:05:30


Dying To Get Ripped: Episode O...

00:46:00

Dying To Get Ripped: Episode One

Documentary On Newstalk

00:46:00


Inflation is at its highest le...

00:07:17

Inflation is at its highest level since February 2024

Down To Business

00:07:17


Executive Chair: Michael Kelly...

00:10:53

Executive Chair: Michael Kelly, CEO FAIN Ireland & Subsidiaries

Down To Business

00:10:53